Pharmaceutical

House GOP inquiry over gain-of-function research target...

House Republicans are seeking testimony from scientist Bernard Moss, a living le...

Opinion: Former Surgeon General Jerome Adams: Prioritiz...

"This is an issue of health equity," writes former Surgeon General Jerome Adams.

STAT+: Doctors’ lobby doubles down on the fight against...

When subscribers stop paying for journal access, where is the money to keep the ...

CDC advisory panel recommends seniors ‘may’ get RSV vac...

If endorsed by CDC director Rochelle Walensky, the recommendation may lead to lo...

STAT+: European companies outline opposition to propose...

Leaders of European pharmaceutical companies on Wednesday said that a proposed o...

Teikoku Pharma bags FDA fast track for post-surgical tr...

The company’s transdermal system delivers dexmedetomidine over four days to help...

FDA grants access to new class of paediatric diabetes m...

Two decades after its approval of metformin, the FDA approves a new class of ora...

CSL doses first patient with haemophilia B gene therapy...

America’s most expensive gene therapy, Hemgenix eliminates the need for prophyla...

AGEPHA Pharma’s LODOCO gets US FDA approval for cardiov...

LODOCO can be utilised as a monotherapy or in combination with cholesterol-lower...

Coya Therapeutics expands COYA 301 patent estate

COYA 301 is designed to improve Treg function in vivo to treat underlying autoim...

US FDA approves Pfizer’s Talzenna with Xtandi for prost...

The FDA approval was based on the findings obtained from the Phase III TALAPRO-2...

DCGI approves emergency use of Gennova’s Covid-19 booster

GEMCOVAC-OM produced significantly higher immune responses when given intraderma...

Bacterial infection may be a “key event” in triggering ...

Endometriosis is a common gynaecological condition that can manifest as a variet...

PharmaTher and Vitruvias partner to commercialise Ketar...

PharmaTher will file an abbreviated new drug application for Ketarx with the US ...

Empress Therapeutics emerges with $50m to fund small mo...

The Flagship-funded startup is banking on accelerating the discovery of small mo...

STAT+: Getting rid of bias in clinical calculators isn’...

Getting rid of bias in clinical calculators isn't as simple as taking race out o...